XNAS
NATR
Market cap221mUSD
Oct 08, Last price
12.57USD
1D
-0.16%
1Q
-40.90%
Jan 2017
-16.20%
IPO
139.43%
Name
Natures Sunshine Products Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, including Asia, Europe, North America, and Latin America. Its comprehensive nutritional offerings cater to general well-being, providing support for blood sugar regulation, bone density, cellular vitality, cognitive sharpness, joint mobility, mood balance, sexual wellness, sleep quality, athletic performance, and visual acuity. Additionally, it supplies specialized products for immune support, cardiovascular health, and digestive function, alongside solutions for weight management. In the personal care segment, their product line includes items such as essential oils and lotions, aloe vera gels, botanical shampoos, herbal skin treatments, dental care products like toothpaste, and skin cleansing formulations. These goods are sold under the company's proprietary Nature's Sunshine and Synergy WorldWide brands, primarily through an extensive network of independent sales consultants. Established in 1972, the organization is headquartered in Lehi, Utah.
Key people
Heidi Wissmiller
Independent Chairman of the Board · since 2025
President · since 2025
Kenneth Romanzi
Chief Executive Officer, Director · since 2025
L. Jones
Executive Vice President, Chief Financial Officer · since 2022
Erich Fritz
Executive Vice President - Global Supply Chain · since 2025
Kevin Herbert
Executive Vice President and President, North America · since 2023
Daniel Norman
Executive Vice President and President of Asia · since 2019
Bryant Yates
Executive Vice President and President of Europe · since 2019
Tracee Comstock
Senior Vice President - Global Human Resources · since 2024
Jonathan Lanoy
Senior Vice President, Chief Accounting Officer · since 2023
Kevin Fuller
Global Chief Marketing Officer · since 2024
Nathan Brower
Executive Vice President, General Counsel, Secretary · since 2017
Independent Director · since 2024
Curtis Kopf
Independent Director · since 2022
Katie May
Independent Director · since 2025
Tess Roering
Independent Director · since 2022
Robert Straus
Independent Director · since 2017
Rong Yang
Independent Director · since 2022
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||